In vitro activity of premafloxacin, a new extended-spectrum fluoroquinolone, against pathogens of veterinary importance
Open Access
- 1 May 1997
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 41 (5) , 1190-1192
- https://doi.org/10.1128/aac.41.5.1190
Abstract
The in vitro activity of premafloxacin against 673 veterinary pathogens was evaluated. Premafloxacin was equivalent to ciprofloxacin, enrofloxacin, and danofloxacin in activity against the gram-negative bacilli but was much more active (MIC for 90% of the strains tested [MIC90], 0.015 to 0.25 microg/ml) than the comparison antimicrobial agents (MIC90, 0.13 to 16.0 microg/ml) against the staphylococci, streptococci, and anaerobes tested.Keywords
This publication has 4 references indexed in Scilit:
- Premafloxacin: a projected veterinary use fluoro-quinolone with significant activity against multi-resistant Gram-positive human pathogensJournal of Antimicrobial Chemotherapy, 1996
- Fluoroquinolones in animal healthJournal of Veterinary Pharmacology and Therapeutics, 1996
- Efficacy of danofloxacin in the therapy of acute bacterial pneumonia in housed beef cattleVeterinary Record, 1991
- Evaluation of antibacterial agents in a high-volume bovine polymorphonuclear neutrophil Staphylococcus aureus intracellular killing assayAntimicrobial Agents and Chemotherapy, 1986